Long-term follow-up of 300 patients with colorectal liver-only metastases: adjuvant mFOLFOX6 after hepatectomy did not improve overall survival (secondary endpoint) vs hepatectomy alone (HR 1.07; 5-year 73.4% vs 80.1%). Primary endpoint DFS was better (HR 0.72).
RCTn = 300
Kanemitsu et al. Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603